Erlocip 100mg (Erlotinib)

Erlocip 100mg (Erlotinib) Tablets

Erlocip 100mg contains erlotinib, a tyrosine kinase inhibitor used for certain types of cancer. In particular, erlotinib is used for selected patients with metastatic non-small cell lung cancer (NSCLC) and, together with gemcitabine, for certain cases of locally advanced, unresectable, or metastatic pancreatic cancer.

The product shown on this page is Erlocip 100, manufactured by Cipla, with packaging indicating 30 tablets. Because erlotinib is a prescription cancer medicine, treatment should take place under the supervision of an oncologist or another qualified healthcare professional.

Erlocip 100mg Uses

Erlocip 100mg contains erlotinib, which blocks specific signals that can help cancer cells grow. Therefore, doctors use erlotinib only for cancers with appropriate clinical and molecular characteristics.

For metastatic NSCLC, current U.S. labeling covers tumors with EGFR exon 19 deletions or exon 21 L858R substitution mutations detected by an FDA-approved test. In addition, erlotinib has a U.S. indication for first-line treatment of locally advanced, unresectable, or metastatic pancreatic cancer in combination with gemcitabine.

As a result, erlotinib is not suitable for every lung or pancreatic cancer. An oncologist should review the diagnosis, molecular test results, previous treatment, and overall health before recommending this medicine.

For authoritative information, visit the U.S. National Library of Medicine MedlinePlus Erlotinib information.

Erlotinib for Lung Cancer

Erlotinib lung cancer treatment focuses on selected patients with metastatic non-small cell lung cancer. More specifically, U.S. labeling identifies erlotinib for tumors with EGFR exon 19 deletions or exon 21 L858R substitution mutations when an FDA-approved test confirms the relevant alteration.

Consequently, molecular testing can play an important role in treatment selection. Your oncologist can explain which EGFR test applies to your cancer and whether erlotinib is an appropriate targeted treatment.

Furthermore, treatment decisions can depend on cancer stage, previous medicines, disease progression, other medical conditions, and potential drug interactions. For that reason, patients should not start erlotinib without appropriate medical evaluation.

What Is Erlotinib?

Erlotinib is a tyrosine kinase inhibitor. It works by blocking the action of certain proteins that can signal cancer cells to multiply.

As a result, erlotinib can slow or inhibit the growth of cancer cells when the tumor depends on the relevant signaling pathway. However, the medicine does not work for every type of cancer.

MedlinePlus explains that erlotinib blocks an abnormal protein involved in cancer-cell multiplication. You can read the complete MedlinePlus Erlotinib Drug Information for additional medical details.

How Does Erlotinib Work?

Erlotinib blocks epidermal growth factor receptor (EGFR) signaling. Some cancer cells use this pathway to grow and multiply.

By inhibiting EGFR-related signaling, the medicine can slow cancer-cell growth in appropriate patients. Therefore, healthcare professionals may use molecular testing to determine whether a tumor has a qualifying EGFR alteration.

For example, FDA-authorized companion-diagnostic information identifies TARCEVA (erlotinib) for appropriate NSCLC patients with EGFR exon 19 deletions or exon 21 L858R alterations. View the FDA companion diagnostic information.

How to Take Erlocip 100mg

Take Erlocip 100mg exactly as prescribed by your oncologist or another qualified healthcare professional. Never change the dose or treatment schedule without medical advice.

Generally, erlotinib is taken once daily on an empty stomach. MedlinePlus advises taking erlotinib at least 1 hour before or 2 hours after eating a meal or snack.

• Take the tablet at approximately the same time each day.
• Take erlotinib on an empty stomach.
• Follow the exact instructions on your prescription.
• Do not take more tablets than prescribed.
• Do not stop treatment without speaking with your healthcare professional.
• Attend all recommended follow-up appointments.

For additional administration information, consult MedlinePlus Erlotinib Drug Information.

What If You Miss a Dose?

If you miss a dose, follow your healthcare professional’s instructions. Do not take a double dose unless your doctor specifically tells you to do so.

Instead, contact your doctor or pharmacist if you are unsure how to handle a missed dose.

Erlotinib 100mg Price

The erlotinib price can vary depending on the manufacturer, brand, strength, pack size, availability, destination country, and pharmacy requirements.

Erlocip 100 is shown on this page as a 30-tablet pack. However, pricing and availability can change over time.

Therefore, check the current product listing for the latest price and availability information. You can also visit our online medicine shop or browse our medicine categories.

Erlotinib Side Effects

Like other prescription medicines, erlotinib can cause side effects. The severity can vary between patients, and some reactions require prompt medical attention.

Common Erlotinib Side Effects

Possible side effects include:

• Skin rash
• Diarrhea
• Loss of appetite
• Tiredness
• Nausea
• Vomiting
• Stomach discomfort
• Dry skin
• Eye irritation
• Changes in hair or nails

In addition, erlotinib can cause skin and gastrointestinal reactions. Your healthcare professional can explain which symptoms require treatment adjustment or additional care.

For comprehensive safety information, review the U.S. DailyMed Erlotinib labeling.

Serious Erlotinib Side Effects

Some reactions can become serious. Therefore, seek medical attention promptly if you develop severe or persistent symptoms.

• New or worsening breathing problems
• Shortness of breath
• Severe or persistent cough
• Severe diarrhea
• Severe abdominal pain
• Yellowing of the skin or eyes
• Unusual bleeding or bruising
• Severe skin blistering or peeling
• Eye pain or significant vision changes
• Severe weakness or dehydration

U.S. prescribing information includes warnings concerning pulmonary toxicity, liver toxicity, renal failure, gastrointestinal perforation, serious skin disorders, ocular disorders, bleeding, and pregnancy-related risks.

Erlocip 100mg Precautions

Before starting erlotinib, tell your healthcare professional about your complete medical history. In addition, provide a list of all prescription medicines, over-the-counter products, vitamins, supplements, and herbal products you use.

• Tell your doctor if you have liver disease.
• Tell your doctor if you have kidney problems.
• Report previous lung disease or infection.
• Discuss stomach or intestinal problems.
• Tell your doctor about existing eye problems.
• Report previous serious medicine allergies.
• Tell your healthcare professional if you use tobacco products.
• Tell them if you are pregnant or planning a pregnancy.
• Tell them if you are breastfeeding.

Furthermore, cigarette smoking can reduce erlotinib exposure and may decrease its effectiveness. Therefore, tell your healthcare professional if you smoke or use tobacco products.

Erlotinib can also increase sensitivity to sunlight. Consequently, avoid unnecessary or prolonged sun exposure and follow appropriate skin-protection advice.

Erlotinib Drug Interactions

Erlotinib can interact with several medicines. Therefore, your doctor or pharmacist should review your complete medication list before treatment.

Medicines and Products to Discuss With Your Doctor

• Antacids
• Proton pump inhibitors
• H2 blockers
• St. John’s wort
• CYP3A4 inhibitors
• CYP3A4 inducers
• CYP1A2 inducers
• Other cancer medicines
• Prescription medicines
• Over-the-counter medicines
• Vitamins and supplements
• Herbal products

For example, MedlinePlus identifies St. John’s wort, proton pump inhibitors, H2 blockers, and other medicines as potential interaction concerns. In addition, antacids may require careful timing around erlotinib doses.

Do not start, stop, or change another medicine without discussing the change with your healthcare professional.

For detailed interaction information, see the MedlinePlus Erlotinib Drug Information.

Erlotinib Warnings

Erlocip 100mg and Tarceva

Tarceva is a brand name associated with erlotinib. Erlocip 100mg also contains erlotinib according to the product packaging shown on this page.

However, products from different manufacturers should not automatically be considered interchangeable. The manufacturer, formulation, packaging, regulatory status, and market authorization can differ.

Therefore, patients should confirm the exact product and strength with their oncologist or pharmacist before switching between brands.

Current U.S. FDA-authorized companion diagnostic information identifies TARCEVA (erlotinib) for appropriate NSCLC patients with specific EGFR alterations. Review the FDA companion diagnostic information.

Erlocip 100mg and U.S. FDA Information

Important for U.S. customers: Erlotinib is an FDA-approved medicine for specific indications. Nevertheless, approval of the active ingredient or another erlotinib product does not automatically establish FDA approval for every brand, manufacturer, or source.

Current U.S. labeling for erlotinib tablets covers metastatic NSCLC with qualifying EGFR exon 19 deletions or exon 21 L858R substitution mutations detected by an FDA-approved test. It also covers first-line treatment of locally advanced, unresectable, or metastatic pancreatic cancer in combination with gemcitabine.

Consequently, this page does not represent Erlocip 100mg as an FDA-approved U.S. product under the Cipla brand name.

For authoritative U.S. information, consult the FDA FDALabel database, Drugs@FDA, and the DailyMed Erlotinib labeling.

Erlotinib Substitutes

The appropriate erlotinib substitute depends on the cancer type, EGFR mutation status, previous treatment, other medical conditions, and treatment goals.

For example, another targeted cancer medicine may contain a different active ingredient and work through a different biological pathway. Consequently, patients should not replace erlotinib with another cancer medicine without guidance from their oncologist.

For additional prescription products, visit our medicine shop or explore our medicine categories.

Frequently Asked Questions About Erlocip 100mg

What is Erlocip 100mg?

Erlocip 100mg is a tablet containing erlotinib. This medicine belongs to the tyrosine kinase inhibitor class and is used for certain cancers under specialist medical supervision.

What is Erlocip 100mg used for?

Erlocip 100mg contains erlotinib, which may be prescribed for selected NSCLC cases and, with gemcitabine, certain pancreatic cancer cases. Therefore, treatment should follow an individualized medical assessment.

What is erlotinib 100mg?

Erlotinib 100mg refers to a tablet containing 100mg of erlotinib. The appropriate strength and dosing schedule depend on the condition being treated and the patient’s individual treatment plan.

Is erlotinib used for lung cancer?

Yes. Erlotinib is used for certain types of NSCLC. For appropriate EGFR-mutated tumors, molecular testing can help determine whether erlotinib is a suitable targeted treatment.

What are the common erlotinib side effects?

Common side effects can include rash, diarrhea, loss of appetite, tiredness, nausea, dry skin, and other skin or gastrointestinal effects.

How should Erlocip 100mg be taken?

Generally, erlotinib is taken once daily on an empty stomach. MedlinePlus recommends taking it at least 1 hour before or 2 hours after eating. Always follow your individual prescription.

What is the price of Erlocip 100mg?

The Erlocip 100mg price depends on the manufacturer, pack size, availability, destination, and applicable pharmacy requirements. Therefore, check the current product listing for the latest price.

Is Erlocip 100mg FDA approved in the USA?

Erlotinib is FDA-approved for specific indications. However, that fact does not automatically establish FDA approval for every brand or product containing erlotinib. U.S. customers should verify the regulatory status of the specific product before purchase or use.

Can erlotinib cause serious side effects?

Yes. Erlotinib can cause serious lung, liver, kidney, skin, gastrointestinal, and eye problems. Therefore, patients should remain under appropriate medical supervision during treatment.

Related Medicines

Explore additional prescription medicines through our online medicine shop. Alternatively, browse our medicine categories to find other available products.

U.S. Purchase and Regulatory Disclaimer

Medical Disclaimer

This product information is provided for general educational purposes only. It does not replace professional medical advice, diagnosis, or treatment.

Always follow the instructions provided by your oncologist, doctor, or pharmacist. In addition, product information, packaging, pricing, availability, and regulatory requirements can vary between countries and may change over time.

If you experience severe breathing problems, severe diarrhea, serious skin reactions, vision changes, severe abdominal pain, yellowing of the skin or eyes, or another serious symptom, seek urgent medical attention.